NLS Pharmaceutics AG (NLSP)
Oct 30, 2025 - NLSP was delisted (reason: merged into NCEL)
0.7620
+0.0220 (2.97%)
Inactive · Last trade price on Oct 30, 2025
NLS Pharmaceutics AG Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 3.07 | 1.67 | 0.9 | 8.95 | 5.43 | 0.09 |
Cash & Short-Term Investments | 3.07 | 1.67 | 0.9 | 8.95 | 5.43 | 0.09 |
Cash Growth | 455.83% | 85.52% | -89.97% | 64.76% | 5695.69% | -57.46% |
Other Receivables | 0.57 | 0.45 | 0.04 | 0.04 | 0.04 | 0.06 |
Receivables | 0.57 | 0.45 | 0.04 | 0.04 | 0.04 | 0.06 |
Prepaid Expenses | 0.37 | 0.05 | 0.07 | 0.19 | 0.22 | 0.01 |
Other Current Assets | 0.02 | 0.07 | 0.82 | 0.07 | 0.04 | 0.03 |
Total Current Assets | 4.04 | 2.23 | 1.82 | 9.25 | 5.72 | 0.2 |
Property, Plant & Equipment | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | - |
Long-Term Deferred Charges | 0.3 | - | - | - | - | 0.95 |
Other Long-Term Assets | 0 | 0 | 0.02 | 0.01 | 0.01 | 0.07 |
Total Assets | 4.34 | 2.23 | 1.85 | 9.28 | 5.76 | 1.21 |
Accounts Payable | 1.02 | 0.52 | 4.63 | 2.37 | 1.74 | 4.01 |
Accrued Expenses | 0.43 | 0.31 | 1.54 | 0.97 | 0.65 | 1.25 |
Short-Term Debt | - | - | 1.63 | - | - | 1.16 |
Current Portion of Long-Term Debt | - | - | - | - | - | 0.61 |
Other Current Liabilities | - | - | 0.11 | 0.01 | 0.02 | 0.18 |
Total Current Liabilities | 1.46 | 0.83 | 7.92 | 3.36 | 2.4 | 7.2 |
Long-Term Debt | - | - | - | - | - | 0.31 |
Long-Term Unearned Revenue | - | - | 2.5 | 2.5 | 2.5 | 2.5 |
Pension & Post-Retirement Benefits | - | - | 0.26 | 0.14 | 0.32 | 0.18 |
Total Liabilities | 1.46 | 0.83 | 10.68 | 6 | 5.22 | 10.2 |
Common Stock | 0.15 | 0.17 | 0.67 | 0.67 | 0.34 | 0.15 |
Additional Paid-In Capital | 77.36 | 72.82 | 61.03 | 60.86 | 42.08 | 20.65 |
Retained Earnings | -74.81 | -74.43 | -70.37 | -58.2 | -41.71 | -29.76 |
Treasury Stock | - | - | - | - | -0.03 | - |
Comprehensive Income & Other | 0.11 | 0.11 | -0.16 | -0.05 | -0.15 | -0.02 |
Total Common Equity | 2.82 | -1.33 | -8.83 | 3.28 | 0.54 | -8.98 |
Shareholders' Equity | 2.88 | 1.41 | -8.83 | 3.28 | 0.54 | -8.98 |
Total Liabilities & Equity | 4.34 | 2.23 | 1.85 | 9.28 | 5.76 | 1.21 |
Total Debt | - | - | 1.63 | - | - | 2.08 |
Net Cash (Debt) | 3.07 | 1.67 | -0.74 | 8.95 | 5.43 | -1.99 |
Net Cash Growth | - | - | - | 64.76% | - | - |
Net Cash Per Share | 1.02 | 1.08 | -0.77 | 18.19 | 18.25 | -11.44 |
Filing Date Shares Outstanding | 4.15 | 3.16 | 1 | 0.81 | 0.37 | 0.3 |
Total Common Shares Outstanding | 4.15 | 3.16 | 0.81 | 0.81 | 0.37 | 0.17 |
Working Capital | 2.58 | 1.4 | -6.1 | 5.89 | 3.32 | -7.01 |
Book Value Per Share | 0.68 | -0.42 | -10.90 | 4.05 | 1.47 | -51.63 |
Tangible Book Value | 2.82 | -1.33 | -8.83 | 3.28 | 0.54 | -8.98 |
Tangible Book Value Per Share | 0.68 | -0.42 | -10.90 | 4.05 | 1.47 | -51.63 |
Machinery | - | 0.02 | 0.01 | 0.01 | 0.01 | - |